Two platforms. One translational thesis. Building on centuries of clinical observation to create the next generation of evidence-based treatments.
Closed-loop tinnitus therapy informed by acupuncture neuroscience. Personalized sound therapy combined with gentle nerve stimulation, guided by real-time physiological feedback.
AI-driven platform transforming clinically validated natural compounds into novel therapeutics for orphan and underserved diseases.
Both platforms share a common foundation: the systematic translation of insights from traditional clinical practice into validated modern therapeutics. SilenEar modernizes acupuncture-derived neuromodulation. NaCo·AI engineers drug candidates from the world's oldest clinical pharmacopoeia. Different modalities — same translational discipline.
MediSense Inc.
Taichung, Taiwan